141 related articles for article (PubMed ID: 2659695)
1. A critique on the interpretation of the lepromin reaction using heat-killed M. leprae vaccine.
Mistry NF; Antia NH
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):110-3. PubMed ID: 2659695
[No Abstract] [Full Text] [Related]
2. Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report.
Job CK; Sanchez RM; Hunt R; Truman RW; Hastings RC
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):394-7. PubMed ID: 8228437
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction.
Gill HK; Mustafa AS; Godal T
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799
[TBL] [Abstract][Full Text] [Related]
4. Leprosy vaccine--a puzzle.
Job CK
Lepr India; 1983 Jan; 55(1):1-7. PubMed ID: 6348409
[No Abstract] [Full Text] [Related]
5. Human vaccination studies in normal and contacts of leprosy patients.
Samuel NM; Stanford JL; Rees RJ; Fairbairn T; Adiga RB
Indian J Lepr; 1984; 56(1):36-47. PubMed ID: 6384380
[No Abstract] [Full Text] [Related]
6. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
[TBL] [Abstract][Full Text] [Related]
7. Rationales for vaccines against leprosy.
Bloom BR
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
[No Abstract] [Full Text] [Related]
8. Antigeneic cross-reactivity between ICRC-bacilli and M. leprae--"in vitro" evaluation.
Kale VP; Bapat CV
Indian J Lepr; 1984; 56(2):219-31. PubMed ID: 6387004
[TBL] [Abstract][Full Text] [Related]
9. Animal vaccination studies with Mycobacterium leprae.
Shepard CC
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
[No Abstract] [Full Text] [Related]
10. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
De Britto RL; Ramanathan VD; Gupte MD
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
[TBL] [Abstract][Full Text] [Related]
11. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
[TBL] [Abstract][Full Text] [Related]
12. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
13. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
[TBL] [Abstract][Full Text] [Related]
14. Ability of the phenolic glycolipid-I antigen of M. leprae to elicit a positive Mitsuda response in the armadillo (Dasypus novemcinctus).
Job CK; Sanchez RM; McCormick GT; Hastings RC
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):299-304. PubMed ID: 3298476
[TBL] [Abstract][Full Text] [Related]
15. Relative cross reactivity of habanin, lepromin and tuberculin in guinea pigs sensitized with homologous and heterologous mycobacteria.
Singh NB; Srivastava A; Gupta HP; Kumar A; Chaturvedi VK
Indian J Lepr; 1988 Jul; 60(3):407-12. PubMed ID: 3143770
[TBL] [Abstract][Full Text] [Related]
16. Antileprosy potentials of ICRC vaccine. A study in patients and healthy volunteers.
Deo MG; Bapat CV; Bhalerao V; Chaturvedi RM; Bhatki WS; Chulawala RG
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):540-9. PubMed ID: 6368417
[No Abstract] [Full Text] [Related]
17. Sensitization studies with potential leprosy vaccine preparations in northern Malawi.
Ponnighaus JM; Fine PE
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of human T-cell clones from BCG and killed M. leprae vaccinated subjects and tuberculosis patients. Recognition of recombinant mycobacterial antigens.
Mustafa AS; Oftung F; Gill HK; Natvig I
Lepr Rev; 1986 Dec; 57 Suppl 2():123-30. PubMed ID: 3106732
[No Abstract] [Full Text] [Related]
19. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
20. Identification of T-cell-activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG, and mycobacterium w.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):265-73. PubMed ID: 3045224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
